KarakadzeMSugarSTeitelbaumI. Icodextrin lowers serum sodium in dose-dependent fashion: a case report. Perit Dial Int2025; 08968608251362906.
2.
GoossenKBeckerMMarshallMR, et al.Icodextrin versus glucose solutions for the once-daily long dwell in peritoneal dialysis: an enriched systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis2020; 75: 830–846.
3.
Bravo González-BlasLGarcía-GagoLAstudillo-JarrínD, et al.Analysis of factors influencing the prognostic significance of hyponatremia in peritoneal dialysis patients. Am J Nephrol2020; 51: 54–64.
4.
TeitelbaumIZhaoJTuC, et al.Associations between serum sodium, peritoneal dialysis-associated peritonitis, and mortality in the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis2025; 86: 84–96.e1.
5.
GoffinEBéchadeCCourivaudC, et al.The double-icodextrin dose randomized controlled trial of a double icodextrin dose for older patients on incremental continuous ambulatory peritoneal dialysis. Kidney Int Rep2025; 10: 2585–2596.
6.
DimitriadisCSekerciogluNPipiliC, et al.Hyponatremia in peritoneal dialysis: epidemiology in a single center and correlation with clinical and biochemical parameters. Perit Dial Int2014; 34: 260–270.
